Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study)
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to consider the following points in patients with hypertension
who complicated by metabolic syndrome for Valsartan basis treatment and an existing, standard
treatment.
- Blood pressure control
- Changing of adiponectin and plasminogen activator inhibitor-1
- Influence metabolizing and cardiac function, etc.